---UP---

U.S. generics drugmaker Mylan said on Thursday that the United States Patent and Trademark Office had rejected Sanofi's infringement claims relating to insulin drug Lantus.


10
Thanks for voting


Reuters

17 Related Articles from 2018-12-13